The Pancreatic Enzymes After Gastrectomy Trial

ConditionGastrectomy
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Leipzig

About this trial

This trial evaluates the effects (e.g. on quality of life, weight) of NORTASE® compared to standard care of patients who have undergone gastrectomy.

Eligibility criteria

Qualifiers

Gastrectomy (total and partial); at least > 50 % of the stomach must be resected

Age 18 or older

Written informed consent

Disqualifiers

Indication for pancreas enzyme therapy

Gastrectomy with palliative intention

UICC (Union for International Cancer Control) Stage IV gastric malignancy

Malnutrition of other aetiology

Trial design

Treatments tested in this trial

  • NORTASE®
  • Placebo

Treatment groups

188 Participants
are divided into 2 treatment groups

Sponsors and collaborators